IBDEI0VS ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31977,0)
 ;;=I69.328^^119^1555^23
 ;;^UTILITY(U,$J,358.3,31977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31977,1,3,0)
 ;;=3^Speech/Lang Deficit Following Cerebvasc Infarc
 ;;^UTILITY(U,$J,358.3,31977,1,4,0)
 ;;=4^I69.328
 ;;^UTILITY(U,$J,358.3,31977,2)
 ;;=^5007495
 ;;^UTILITY(U,$J,358.3,31978,0)
 ;;=E04.0^^119^1556^39
 ;;^UTILITY(U,$J,358.3,31978,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31978,1,3,0)
 ;;=3^Nontoxic Diffuse Goiter
 ;;^UTILITY(U,$J,358.3,31978,1,4,0)
 ;;=4^E04.0
 ;;^UTILITY(U,$J,358.3,31978,2)
 ;;=^5002477
 ;;^UTILITY(U,$J,358.3,31979,0)
 ;;=E04.1^^119^1556^41
 ;;^UTILITY(U,$J,358.3,31979,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31979,1,3,0)
 ;;=3^Nontoxic Single Thyroid Nodule
 ;;^UTILITY(U,$J,358.3,31979,1,4,0)
 ;;=4^E04.1
 ;;^UTILITY(U,$J,358.3,31979,2)
 ;;=^5002478
 ;;^UTILITY(U,$J,358.3,31980,0)
 ;;=E04.2^^119^1556^40
 ;;^UTILITY(U,$J,358.3,31980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31980,1,3,0)
 ;;=3^Nontoxic Multinodular Goiter
 ;;^UTILITY(U,$J,358.3,31980,1,4,0)
 ;;=4^E04.2
 ;;^UTILITY(U,$J,358.3,31980,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,31981,0)
 ;;=E01.1^^119^1556^36
 ;;^UTILITY(U,$J,358.3,31981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31981,1,3,0)
 ;;=3^Iodine-Deficiency Related Multinodular (Endemic) Goiter
 ;;^UTILITY(U,$J,358.3,31981,1,4,0)
 ;;=4^E01.1
 ;;^UTILITY(U,$J,358.3,31981,2)
 ;;=^5002465
 ;;^UTILITY(U,$J,358.3,31982,0)
 ;;=E05.00^^119^1556^56
 ;;^UTILITY(U,$J,358.3,31982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31982,1,3,0)
 ;;=3^Thyrotoxicosis w/ Diffuse Goiter w/o Thyrotoxic Crisis
 ;;^UTILITY(U,$J,358.3,31982,1,4,0)
 ;;=4^E05.00
 ;;^UTILITY(U,$J,358.3,31982,2)
 ;;=^5002481
 ;;^UTILITY(U,$J,358.3,31983,0)
 ;;=E05.01^^119^1556^55
 ;;^UTILITY(U,$J,358.3,31983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31983,1,3,0)
 ;;=3^Thyrotoxicosis w/ Diffuse Goiter w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,31983,1,4,0)
 ;;=4^E05.01
 ;;^UTILITY(U,$J,358.3,31983,2)
 ;;=^5002482
 ;;^UTILITY(U,$J,358.3,31984,0)
 ;;=E05.90^^119^1556^58
 ;;^UTILITY(U,$J,358.3,31984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31984,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/o Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,31984,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,31984,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,31985,0)
 ;;=E05.91^^119^1556^57
 ;;^UTILITY(U,$J,358.3,31985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31985,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,31985,1,4,0)
 ;;=4^E05.91
 ;;^UTILITY(U,$J,358.3,31985,2)
 ;;=^5002493
 ;;^UTILITY(U,$J,358.3,31986,0)
 ;;=E89.0^^119^1556^50
 ;;^UTILITY(U,$J,358.3,31986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31986,1,3,0)
 ;;=3^Postprocedural Hypothyroidism
 ;;^UTILITY(U,$J,358.3,31986,1,4,0)
 ;;=4^E89.0
 ;;^UTILITY(U,$J,358.3,31986,2)
 ;;=^5003035
 ;;^UTILITY(U,$J,358.3,31987,0)
 ;;=E03.2^^119^1556^32
 ;;^UTILITY(U,$J,358.3,31987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31987,1,3,0)
 ;;=3^Hypothyroidism d/t Meds/Oth Exogenous Substances
 ;;^UTILITY(U,$J,358.3,31987,1,4,0)
 ;;=4^E03.2
 ;;^UTILITY(U,$J,358.3,31987,2)
 ;;=^5002471
 ;;^UTILITY(U,$J,358.3,31988,0)
 ;;=E03.9^^119^1556^33
 ;;^UTILITY(U,$J,358.3,31988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31988,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,31988,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,31988,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,31989,0)
 ;;=E06.0^^119^1556^53
 ;;^UTILITY(U,$J,358.3,31989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31989,1,3,0)
 ;;=3^Thyroiditis,Acute
 ;;^UTILITY(U,$J,358.3,31989,1,4,0)
 ;;=4^E06.0
 ;;^UTILITY(U,$J,358.3,31989,2)
 ;;=^2692
 ;;^UTILITY(U,$J,358.3,31990,0)
 ;;=E06.1^^119^1556^54
 ;;^UTILITY(U,$J,358.3,31990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31990,1,3,0)
 ;;=3^Thyroiditis,Subacute
 ;;^UTILITY(U,$J,358.3,31990,1,4,0)
 ;;=4^E06.1
 ;;^UTILITY(U,$J,358.3,31990,2)
 ;;=^119376
 ;;^UTILITY(U,$J,358.3,31991,0)
 ;;=C73.^^119^1556^37
 ;;^UTILITY(U,$J,358.3,31991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31991,1,3,0)
 ;;=3^Malig Neop of Thyroid Gland
 ;;^UTILITY(U,$J,358.3,31991,1,4,0)
 ;;=4^C73.
 ;;^UTILITY(U,$J,358.3,31991,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,31992,0)
 ;;=E10.21^^119^1556^8
 ;;^UTILITY(U,$J,358.3,31992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31992,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,31992,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,31992,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,31993,0)
 ;;=E10.9^^119^1556^12
 ;;^UTILITY(U,$J,358.3,31993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31993,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,31993,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,31993,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,31994,0)
 ;;=E11.21^^119^1556^17
 ;;^UTILITY(U,$J,358.3,31994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31994,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,31994,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,31994,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,31995,0)
 ;;=E11.39^^119^1556^18
 ;;^UTILITY(U,$J,358.3,31995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31995,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Ophthalmic Complication NEC
 ;;^UTILITY(U,$J,358.3,31995,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,31995,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,31996,0)
 ;;=E11.43^^119^1556^15
 ;;^UTILITY(U,$J,358.3,31996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31996,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Autonomic Neuropathy
 ;;^UTILITY(U,$J,358.3,31996,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,31996,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,31997,0)
 ;;=E11.59^^119^1556^13
 ;;^UTILITY(U,$J,358.3,31997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31997,1,3,0)
 ;;=3^DM Type 2 w/ Circulatory Complications NEC
 ;;^UTILITY(U,$J,358.3,31997,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,31997,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,31998,0)
 ;;=E11.618^^119^1556^14
 ;;^UTILITY(U,$J,358.3,31998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31998,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Arthropathy NEC
 ;;^UTILITY(U,$J,358.3,31998,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,31998,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,31999,0)
 ;;=E11.621^^119^1556^16
 ;;^UTILITY(U,$J,358.3,31999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31999,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,31999,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,31999,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,32000,0)
 ;;=E11.622^^119^1556^20
 ;;^UTILITY(U,$J,358.3,32000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32000,1,3,0)
 ;;=3^DM Type 2 w/ Skin Ulcer NEC
 ;;^UTILITY(U,$J,358.3,32000,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,32000,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,32001,0)
 ;;=E11.65^^119^1556^19
 ;;^UTILITY(U,$J,358.3,32001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32001,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,32001,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,32001,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,32002,0)
 ;;=E11.9^^119^1556^21
 ;;^UTILITY(U,$J,358.3,32002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32002,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,32002,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,32002,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,32003,0)
 ;;=E13.9^^119^1556^22
 ;;^UTILITY(U,$J,358.3,32003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32003,1,3,0)
 ;;=3^Diabetes Mellitus (Secondary) w/o Complications NEC
 ;;^UTILITY(U,$J,358.3,32003,1,4,0)
 ;;=4^E13.9
 ;;^UTILITY(U,$J,358.3,32003,2)
 ;;=^5002704
 ;;^UTILITY(U,$J,358.3,32004,0)
 ;;=E16.2^^119^1556^29
 ;;^UTILITY(U,$J,358.3,32004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32004,1,3,0)
 ;;=3^Hypoglycemia,Unspec
